Provided by Tiger Trade Technology Pte. Ltd.

Aligos Therapeutics, Inc.

5.31
-0.0100-0.19%
Post-market: 5.310.00000.00%16:15 EDT
Volume:37.36K
Turnover:197.06K
Market Cap:33.16M
PE:-0.73
High:5.53
Open:5.25
Low:5.08
Close:5.32
52wk High:13.69
52wk Low:3.98
Shares:6.24M
Float Shares:3.68M
Volume Ratio:1.35
T/O Rate:1.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.3016
EPS(LYR):-2.4500
ROE:-113.59%
ROA:-49.12%
PB:1.04
PE(LYR):-2.17

Loading ...

Mar 09, 2023

Major Issues Report

8-K - Current report
Mar 09, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 09, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 27, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 22, 2022

Correspondence

CORRESP [Cover] - Correspondence
Nov 02, 2022

Major Issues Report

8-K - Current report
Nov 02, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 04, 2022

Major Issues Report

8-K - Current report
Aug 04, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 27, 2022

Major Issues Report

8-K - Current report
May 04, 2022

Major Issues Report

8-K - Current report
May 04, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 30, 2022

Major Issues Report

8-K - Current report
Mar 22, 2022

Major Issues Report

8-K - Current report
Mar 10, 2022

Major Issues Report

8-K - Current report
Mar 10, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]